Ibucalmin

Ibuprofen, the active ingredient in Ibucalmin, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats mild to moderate pain, fever, and inflammatory conditions such as arthritis in adults. GNH USA supplies Ibucalmin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibucalmin (ibuprofen) works within the NSAID class to address common pain‑related and inflammatory pathways. - Mild to moderate pain: provides analgesic relief by reducing pain signals. - Fever: lowers elevated body temperature through antipyretic action. - Inflammatory conditions such as arthritis: decreases swelling and improves joint mobility.

Adverse reactions can vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Renal impairment or acute kidney injury. - Severe allergic reactions such as angioedema or anaphylaxis. - Cardiovascular events including myocardial infarction or stroke, particularly with high‑dose or prolonged use.

Before using Ibucalmin, consider the following safety measures. - Assess renal function: avoid use in patients with severe kidney disease. - Evaluate gastrointestinal risk: use cautiously in those with a history of ulcers or bleeding. - Monitor cardiovascular status: limit use in patients with established heart disease. - Avoid concurrent use with other NSAIDs or anticoagulants unless directed by a clinician. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Ibucalmin may interact with several drug classes, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - High‑dose aspirin: additive gastrointestinal toxicity. - Selective COX‑2 inhibitors: heightened cardiovascular risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may potentiate renal adverse effects. - Lithium: ibuprofen can raise serum lithium levels.